According to a new report Global Hybrid Imaging Market, published by KBV Research, The Global Hybrid Imaging Market size is expected to reach $9.1 billion by 2025, rising at a market growth of 4.4% CAGR during the forecast period. The considerable importance of a combined analysis of anatomic and molecular data to diagnose diseases is a key driver of the global market for hybrid imaging systems. In addition to the advantages of hybrid imaging and its growing use in diagnostics, there is a significant opportunity for combination hybrid imaging PET or SPECT with MRI.

PET/CT systems retained the largest market share in 2018 mainly due to its growing use in the field of oncology. The SPET/CT segment has been estimated to grow at the significant growth over the forecast period. Standalone SPET devices have been commonly used for nuclear medicine.

Oncology had the largest share in 2018 owing to an increased number of cancer cases. The cardiology segment would grow at the highest growth rate of 5.3% during the forecast period mostly due to an increase in the prevalence of coronary atherosclerosis and the implementation of multimodal imaging for diagnosis.
Hospitals recorded the largest market share in 2018, primarily due to the increased installation of multimodal imaging devices in hospitals. The Diagnostic Imaging Centers market is expected to witness a CAGR of 4.6% during (2019-2025).

North America experienced a dominant market share in 2018. The rising prevalence of cancer and cardiovascular disease in the North American countries is expected to fuel market growth. The Asia Pacific is expected to grow at the fastest pace over the forecast period. The growing use of hybrid devices such as PET/CT in different radiology departments across the area is expected to add to market growth. The Europe market is anticipated to grow at a CAGR of 4% during (2019-2025).

Structural Insights: https://www.kbvresearch.com/hybrid-imaging-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Siemens AG (Siemens Healthineers), Canon, Inc. (Canon Medical Systems Corporation), General Electric (GE) Co. (GE Healthcare), Hitachi, Ltd. (Hitachi Healthcare), Koninklijke Philips N.V., PerkinElmer, Inc., Bruker Corporation, Atlantis Worldwide, LLC., Cubersa, Inc., and Amber Diagnostics, Inc.
Global Hybrid Imaging Market Segmentation

By Application
• Oncology
• Ophthalmology
• Cardiology
• Brain & Neurology
• Other Applications

By Type
• PET/CT systems
• SPET/CT systems
• PET/MR systems
• OCT/Fundus Imaging System
• Other types

By End User
• Hospitals
• Diagnostic Imaging Centers
• Other End Use

By Geography
North America
• US
• Canada
• Mexico
• Rest of North America

Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled
• Siemens AG (Siemens Healthineers)
• Canon, Inc. (Canon Medical Systems Corporation)
• General Electric (GE) Co. (GE Healthcare)
• Hitachi, Ltd. (Hitachi Healthcare)
• Koninklijke Philips N.V.
• PerkinElmer, Inc.
• Bruker Corporation
• Atlantis Worldwide, LLC
• Cubersa, Inc.
• Amber Diagnostics, Inc.